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Background: Well-differentiated liposarcoma (WDL)/atypical lipomatous tumor (ALT) is considered a low-grade
malignancy that rarely metastasizes but should be carefully followed because recurrence or dedifferentiation may
occur. It is recognized that WDL and ALT are essentially synonymous, describing lesions that are identical both
morphologically and karyotypically, and that site-specific variations in behavior relate only to surgical resectability.
Preoperative differential diagnosis between lipoma and ALT has been well studied because their clinical and image
characteristics are very similar. We evaluated the factors that may differentiate ALTs from lipomas, and validated a
tentative scoring system for the diagnosis of the 2 tumor types.
Methods: Forty-eight lipomas and 12 ALTs were included. The mean age, location and depth of the tumor as well as
the compartment were not significantly different between the 2 groups. To evaluate the vascularity of the tumors, the
average number of intratumoral vessels on pathological sections was calculated and compared between cases of
lipoma and ALT.
Results: The tumor size was significantly larger in ALT cases than in lipoma cases (P < 0.001). Magnetic resonance
imaging (MRI) revealed septal structures in 91.6% of ALTs, whereas 20.8% of lipomas showed septa. Contrast
enhancement in MRI was found significantly more often in ALTs (81.2%) than in lipomas (18.8%) (P < 0.001). We created
a “ALT score” to discriminate between lipoma and ALT (0–6 points). ALT cases gave significantly higher point values
(average 5.1 points) than lipoma cases (average 1.7 points) (P < 0.001). We found a significantly increased number of
vessels in cases of ALT than in cases of lipoma (P = 0.001).
Conclusions: Our ALT score may help surgeons to differentiate a suspected ALT from a lipoma and could recommend
a marginal resection in cases of suspected ALT. Increased intratumoral vascularity in ALT is reflected in the MRI findings
and may play a key role in the acquisition of a malignant phenotype in adipocytic tumors.
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Table 1 Summary of patient characteristics
Lipoma ALT P-value
Average (range)
Age 59 (27–77) 62 (44–80) 0.27
Gender Cases (%)
Male 25 (52.1) 7 (58.3) 0.70
Female 23 (47.9) 5 (41.7)
Location
Extremity 29 (60.4) 8 (66.7) 0.70
Trunk 19 (39.6) 4 (33.3)
Depth
Superficial 24 (50.0) 4 (33.3) 0.30
Deep 24 (50.0) 8 (66.7)
Compartment
Intracompartment 5 (16.1) 2 (16.7) 0.97
Extracompartment 26 (83.9) 10 (83.7)
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Adipocytic tumors are the soft tumors most frequently
encountered by orthopaedic physicians in clinics. Benign
adipocytic tumors, lipomas, can be conservatively ob-
served unless patients experience symptoms due to the
presence of the mass. However, tumors that are pre-
operatively suspected to be lipomas, can sometimes be
intermediate (locally aggressive)-type adipocytic tumors
or well-differentiated liposarcoma (WDL)/atypical lipo-
matous tumors (ALTs). WDL is considered a low-grade
malignancy that rarely metastasizes but should be care-
fully followed because recurrence or dedifferentiation
may occur [1]. It is recognized that WDL and ALT are
essentially synonymous, describing lesions that are iden-























Figure 1 Comparison of magnetic resonance imaging (MRI) findings i
tumor diameter was significantly larger in ALTs than lipomas (*P < 0.001). (B
the ALT cases and rarely in lipoma cases (*P < 0.001).site-specific variations in behavior relate only to surgical
resectability [2]. The term WDL is now used for tumors
of the retroperitoneum, mediastinum, and deep pelvis,
whereas the term ALT includes tumors of the extrem-
ities and superficial sites. Preoperative differential diag-
nosis between lipoma and WDL/ALT has been well
studied because their clinical and image characteristics
are very similar [3,4]. Magnetic resonance imaging
(MRI) is currently the most popular modality for the
screening and diagnosis of soft tissue tumors, including
adipocytic tumors. MRI findings of lipomas usually show
high intensity in both T1- and T2-weighted images,
reflecting their uniform structure with fatty tissue. In
contrast, high-grade liposarcomas, including myxoid,
round cell, pleomorphic, and dedifferentiated liposacr-
coma, show low intensity in T1-weighted images. The
MRI features of WDL/ALT are similar to those of lip-
oma, which makes differentiation between them difficult.
In general, a larger size, deeper localization, or enhance-
ment with contrast medium in MRI is suggestive of ma-
lignant soft tissue tumors. In this study, we evaluated
the factors that may differentiate ALTs from lipomas
and aimed to establish a feasible scoring system to help
in the diagnosis of the 2 tumor types. Furthermore, we
examined if increased vascularity in the surgical speci-
men could be a finding that pathologically differentiates
ALTs from lipomas, and affect the clinical behavior of
ALT.
Methods
We retrospectively reviewed the records of 48 patients
with lipomas and 12 patients with ALT. According to
the definitions of WDL and ALT, tumors of the extrem-
ities and superficial trunk come under the term ALT [2].
In this series, we aimed to study tumors of the extrem-




















n cases of lipoma and well-differentiated lipoma (ALT). (A) The





































Figure 2 Pathological analysis and evaluation of intratumoral vascularity. In lipoma specimens, mature adipocytes were uniformly observed
without high variation in size (A, B). By contrast, adipocytes in ALT showed significant variation in size (C), and lipoblasts with cytoplasmic vacuoles were
occasionally found around the thick septa (D). Septa in ALTs were thicker than those in lipomas, and vessel formation was observed both inside and
outside of the thick septa (E). Vascular formation was found significantly more often in ALTs than in lipomas (F) (*P= 0.001). Original magnification, ×20
(E), ×40 (A, C), ×100 (B, D).
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included in this study. All patients underwent surgical
excision of the tumor, and a pathologist established the
pathological diagnosis. Age, sex, tumor location (limb or
trunk), size (diameter in MRI), and depth (superficial, sub-
cutaneous or deep, or under the fascia), and intracompart-
mental or extracompartmental location were evaluated in
all cases. In the MRI analysis, the presence of septal struc-
tures (more than 2 mm thick) was assessed. On fat-
suppressed T1-weighted images after the administration
of contrast-enhancing medium, enhancement of intratu-
moral lesions was evaluated in all cases. All tumors wereresected by marginal resection, and pathological diagnosis
was established by pathologists.
To evaluate the vascularity of the tumors, the number
of vessels was counted in 10 randomly taken micro-
scopic pictures of hematoxylin and eosin stained sec-
tions. The average number of intratumoral vessels was
calculated and compared between cases of lipoma and
ALT.
The average value of age and tumor size was analyzed
with a Student’s t-test. All other factors were analyzed
using the Chi-square test. A P value of less than 0.05
was considered significant.





























Figure 3 Comparison of the ALT score (0–6 points) in lipoma
and ALT groups. The majority of lipoma cases showed a ALT score
of less than 2 points, whereas the ALT cases showed significantly
high points values (average of 5.1 points) (*P < 0.001).
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Results
The mean ages of the patients with lipoma and ALT
were 59 (range, 27–77) and 62 (range, 44–78) years, re-
spectively, and the difference was not statistically signifi-
cant (P = 0.22). The location (trunk or extremity) and
depth of the tumor (superficial or deep) and intracom-
partmental or extracompartmental location were not sig-
nificantly different between the 2 groups (Table 1). The
tumor size was significantly larger in cases of ALTs
(average, 15.3 cm) than in cases of lipomas (average,
8.9 cm) (P < 0.001, Figure 1A). On T2-weighted MRI,
septal structures were found in 11 of 12 (91.6%) cases of
ALT, whereas 10 of 48 (20.8%) cases of lipoma showed
septa (P < 0.001, Figure 1B). ALT was significantly inten-
sively enhanced by gadolinium in MRI in 81.2% ALT
cases, whereas the incidence was 18.8% in lipoma cases
(P < 0.001, Figure 1B).
In pathological examination of the lipoma specimens,
mature adipocytes were uniformly arranged without high
variations in size (Figure 2A,B). In contrast, adipocytes
in ALT showed marked variation in size, and many
hyperchromatic stromal cells were found around the
thick septa (Figure 2C,D). Monovacuolated or multiva-
cuolated lipoblasts are considered a hallmark of liposar-
coma, although WDL/ALTs do not always contain
lipoblasts. In our study, atypical lipoblasts with cytoplas-
mic vacuoles and scalloped nuclei were seen in some
cases (Figure 2D). Although vessels were found inside
the fibrous septa in both lipomas and ALTs, septa were
much less frequently found in lipomas. In addition, septa
in ALTs were thicker than those in lipomas, and vessel
formation was observed both inside and outside of the
thick septa (Figure 2E). Analysis of the vascularity in the
tumors revealed that ALTs had significantly more vessels
(average 11.1/view field) than lipomas (average 3.82/view
field) (P = 0.001, Figure 2F).
In order to develop a new diagnostic tool for adipocy-
tic tumors, we created a scoring system to discriminate
between lipomas and ALTs by considering the tumor
size, depth, septa, and enhancement on MRI (Table 2).
Total points for the scoring system ranged from 0 to 6
depending on the positivity of those findings, and we ex-
pected that a high number of points would suggest the
increased probability of the diagnosis of ALT. Almost all
lipoma cases gave low scores (average 1.7 points),
whereas ALT cases gave significantly high point values
(average of 5.1 points) (P < 0.001, Figure 3). Based on
this scoring system, the diagnosis of ALT was possible
with 100% sensitivity and 77% specificity.
One of the 12 ALT patients had a recurrence with de-
differentiation 4 years after resection. At the time ofdedifferentiation, the entire tumor measured 28 cm and
contained 5 cm of a dedifferentiated lesion. The tumor
was deep-seated, had septa, and was enhanced by gado-
linium in MRI (6 points by the ALT scoring system).
This patient underwent wide resection of the ALT and
dedifferentiated lesion. Although there was no sign of re-
currence or metastasis 3 months after the resection,
careful follow-up is required.
Discussion
Adipocytic tumors represent the largest single group of
mesenchymal tumors because of the high prevalence of
lipomas and angiolipomas [2]. Although orthopaedic
surgeons rarely encounter malignant soft tissue tumors,
relatively large numbers of adipocytic tumors are found
A B C
Figure 4 A 34-year-old male patient with a lipoma measuring 12 cm in diameter. Axial T1- and T2- weighted MRIs showed a homogenously
high intramuscular mass (A, B). T1-weighted fat saturation gadolinium-enhanced MRI showed no enhancement of the tumor (C). This case
obtained 2 points using the ALT score.
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mors, regardless of their benign or malignant status,
could be large in size without inducing any symptoms.
In this study, 31 out of 48 patients with lipomas had tu-
mors larger than 5 cm. Patients with tumors less than
5 cm in size and superficially located may undergo re-
sectional biopsy for diagnosis; however, diagnostic im-
aging studies are usually performed preoperatively. If
computed tomography or MRI examinations reveal a
soft tumor with lipomatous content in the majority of
the tumor volume, lipoma or WDL/ALT is suspected ra-
ther than a high-grade soft tissue sarcoma (Figures 4
and 5). Even though the tumor may be large in size,
asymptomatic lipomas do not necessarily require surgi-
cal resection. On the other hand, treatment of WDL/
ALT is still controversial because of its very low malig-
nancy potential [1,2,5,6]. Because WDL/ALTs have no
potential for metastasis unless they undergo dedifferenti-
ation, some pathologists suggest that the term “atypical
lipomatous tumor” is more appropriate to use rather
than “liposarcoma” [1]. The rate of dedifferentiation of
WDL/ALT was previously reported to be 1–4% [6-8].
However, dedifferentiated liposarcoma (DDL) shows
much more malignant potential than conventional
WDL/ALT with a 5-year survival rate of 60–70% [9,10].
Okada et al. reviewed 18 cases of primary (de novo)
DDL in the extremities and reported that the duration
of the symptoms was an average of 38 months, and 9A B
Figure 5 A 40-year-old male patient with ALT measuring 15 cm in dia
image (B) clearly demonstrated thick septa (arrows). T1-weighted fat satura
these septa (C). This case obtained 5 points using the ALT score.patients showed rapid growth of long-standing tumors
[10]. This result suggests that if preoperative diagnosis
of WDL/ALT is easily made, surgeons could recommend
resection of the tumor before it dedifferentiates.
Previously, other researchers reported on the signifi-
cance of septal structures in WDL/ALT [4,11]. Gaskin
et al. tried to differentiate WDL/ALTs from lipomas
based upon the viewpoint that simple lipomas may con-
tain thin, discrete septa, whereas WDL/ALTs usually
contain thick or nodular septa or enhancement [12].
MRI analysis of 126 fatty masses by musculoskeletal ra-
diologists reached the correct diagnosis in all 6 WDL/
ALT cases (sensitivity, 100%); however, 10 of the sus-
pected ALT tumor cases turned out to be variants of be-
nign lipomas, such as chondroid lipoma, osteolipoma, or
angiolipoma. The differential diagnosis of lipomatous tu-
mors largely depended on the decisions made by the
musculoskeletal radiologists. It would be useful for non-
oncologist orthopedic surgeons if simplified diagnostic
criteria were available. Therefore, we have created a
scoring system to discriminate between lipoma and ALT
by the combination of 4 values (Table 2). The score can
be measured if enhanced MRI is performed (Figures 4
and 5). Based on this score, diagnosis of ALT is possible
with 100% sensitivity and 77% specificity. This result is
superior to MRI findings of intratumoral septa alone as
a diagnostic finding, which showed 91.7% sensitivity and
74.2% specificity. Although the prevalence of hibernomaC
meter. Axial T1-weighted image (A) and T1- weighted fat saturation
tion after gadolinium administration demonstrated enhancement of
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WDL/ALT. Vassos recently reported that hibernomas
show spotty areas of contrast enhancement as well as
prominent fibrovascular septa on MRI [13]. Hibernomas
exhibit very high standard uptake values (SUVs) on
[18F]fluorodeoxyglucose (FDG)-based positron emission
tomography (PET) because they contain abundant mito-
chondria and are highly metabolically active [14]. One of
our cases of hibernoma showed an SUV >40, suggesting
that PET might be useful to distinguish hibernomas
from WDL/ALTs (manuscript in preparation).
Treatment for WDL/ALT is still controversial because
the recurrence rate after surgical resection of WDL/ALT
is variable, ranging from 0–69% [15-17]. The recurrence
of ALT in our series was seen in only 1 case (8.3%), simi-
lar to the findings in the report by Sommerville et al.
showing an 8% local recurrence rate after marginal re-
section of 61 cases of ALT [6]. We agree with Sommer-
ville et al. and Kubo et al. in the idea of “conservative”
surgery for ALT to preserve the major vessels or nerves
[18]. However, for recurrent ALT cases, we recommend
as wide of a resection as possible because tumor margins
are not usually clear and there is an increased chance of
dedifferentiation. An increased number of intratumoral
angiogenic vessels was revealed to be a significant factor
that differentiates ALTs from lipomas in this study. Be-
cause angiolipomas are characterized by rich vasculature
in mature adipose tissue, vascularity alone is not useful
for the differentiation of ALTs from lipomas. As Folk-
mann’s group proposed, angiogenesis could be a switch
that turns on the malignant phenotype in adipocytic tu-
mors [19]. In our study, the highest number of intratu-
moral vessels (21.4 vessels per field) was observed in the
case of ALT recurrence, which eventually dedifferen-
tiated. Contrast enhancement MRI definitely reflects the
vascular supply in the tumor and also supports the
theory.
Conclusion
Our ALT score (0–6 points) can be used to differentiate
ALTs from lipomas based on MRI. If the score is equal to
or higher than 3, we recommend marginal resection of the
tumor to confirm the pathological diagnosis. Cut-off value
should be validated by the future study because of the
number of the case is not large in this study. Once the
diagnosis of ALT is established, careful follow-up is rec-
ommended, especially for cases with increased vascularity.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SN, MY, HSa and HSh participated in the diagnosis and surgical treatment of
the patient. TS and YI helped draft and finalize the manuscript. SK performed
the pathological examination and proof reading of the manuscript. All
authors read and approved the manuscript.Acknowledgements
We thank Shinichi Kitajima and Akihide Tanimoto for performing pathological
analysis. This work was supported by JSPS KAKENHI Grant Number 24592237.
Author details
1Department of Orthopaedic Surgery, Graduate School of Medical and
Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima-city,
Kagoshima 890-8520, Japan. 2The Near-Future Locomotor Organ Medicine
Creation Course (Kusunoki Kai), Graduate School of Medical and Dental
Sciences, Kagoshima University, Kagoshima, Japan. 3Department of Medical
Joint Materials, Graduate School of Medical and Dental Sciences, Kagoshima
University, Kagoshima, Japan.
Received: 2 May 2013 Accepted: 2 February 2015
References
1. Laurino L, Furlanetto A, Orvieto E, Dei Tos AP. Well-differentiated liposarcoma
(atypical lipomatous tumors). Semin Diagn Pathol. 2001;18:258–62.
2. Fletcher CDM, World Health Organization., International Agency for
Research on Cancer. WHO classification of tumours of soft tissue and bone.
4th ed. Lyon: IARC Press; 2013.
3. Doyle AJ, Pang AK, Miller MV, French JG. Magnetic resonance imaging of
lipoma and atypical lipomatous tumour/well-differentiated liposarcoma:
observer performance using T1-weighted and fluid-sensitive MRI. J Med
Imaging Radiat Oncol. 2008;52:44–8.
4. Ohguri T, Aoki T, Hisaoka M, Watanabe H, Nakamura K, Hashimoto H,
et al. Differential diagnosis of benign peripheral lipoma from well-
differentiated liposarcoma on MR imaging: is comparison of margins and
internal characteristics useful? AJR Am J Roentgenol. 2003;180:1689–94.
5. Lucas DR, Nascimento AG, Sanjay BK, Rock MG. Well-differentiated
liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol.
1994;102:677–83.
6. Sommerville SM, Patton JT, Luscombe JC, Mangham DC, Grimer RJ. Clinical
outcomes of deep atypical lipomas (well-differentiated lipoma-like liposarcomas)
of the extremities. ANZ J Surg. 2005;75:803–6.
7. Bassett MD, Schuetze SM, Disteche C, Norwood TH, Swisshelm K, Chen X, et al.
Deep-seated, well differentiated lipomatous tumors of the chest wall and
extremities: the role of cytogenetics in classification and prognostication.
Cancer. 2005;103:409–16.
8. Kooby DA, Antonescu CR, Brennan MF, Singer S. Atypical lipomatous tumor/
well-differentiated liposarcoma of the extremity and trunk wall: importance
of histological subtype with treatment recommendations. Ann Surg Oncol.
2004;11:78–84.
9. Coindre JM, Pedeutour F, Aurias A. Well-differentiated and dedifferentiated
liposarcomas. Virchows Arch. 2010;456:167–79.
10. Okada K, Hasegawa T, Kawai A, Ogose A, Nishida J, Yanagisawa M, et al.
Primary (de novo) dedifferentiated liposarcoma in the extremities: a multi-
institution Tohoku Musculoskeletal Tumor Society study of 18 cases in
northern Japan. Jpn J Clin Oncol. 2011;41:1094–100.
11. Arkun R, Memis A, Akalin T, Ustun EE, Sabah D, Kandiloglu G. Liposarcoma
of soft tissue: MRI findings with pathologic correlation. Skeletal Radiol.
1997;26:167–72.
12. Gaskin CM, Helms CA. Lipomas, lipoma variants, and well-differentiated
liposarcomas (atypical lipomas): results of MRI evaluations of 126
consecutive fatty masses. AJR Am J Roentgenol. 2004;182:733–9.
13. Vassos N, Lell M, Hohenberger W, Croner RS, Agaimy A. Deep-seated huge
hibernoma of soft tissue: a rare differential diagnosis of atypical lipomatous
tumor/well differentiated liposarcoma. Int J Clin Exp Pathol. 2013;6:2178–84.
14. Robison S, Rapmund A, Hemmings C, Fulham M, Barry P. False-positive
diagnosis of metastasis on positron emission tomography-computed
tomography imaging due to hibernoma. J Clin Oncol. 2009;27:994–5.
15. Evans HL, Soule EH, Winkelmann RK. Atypical lipoma, atypical intramuscular
lipoma, and well differentiated retroperitoneal liposarcoma: a reappraisal of
30 cases formerly classified as well differentiated liposarcoma. Cancer.
1979;43:574–84.
16. Rozental TD, Khoury LD, Donthineni-Rao R, Lackman RD. Atypical lipomatous
masses of the extremities: outcome of surgical treatment. Clin Orthop Relat
Res. 2002;398:203–11.
17. Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep
soft tissue of the extremities, retroperitoneum, and miscellaneous sites.
Nagano et al. BMC Musculoskeletal Disorders  (2015) 16:36 Page 7 of 7A follow-up study of 92 cases with analysis of the incidence of
“dedifferentiation”. Am J Surg Pathol. 1992;16:1051–8.
18. Kubo T, Sugita T, Shimose S, Arihiro K, Ochi M. Conservative surgery for
well-differentiated liposarcomas of the extremities adjacent to major
neurovascular structures. Surg Oncol. 2006;15:167–71.
19. Naumov GN, Folkman J, Straume O. Tumor dormancy due to failure of
angiogenesis: role of the microenvironment. Clin Exp Metastasis.
2009;26:51–60.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
